Qube Research & Technologies (QRT)’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ABCL
BBA
Qube Research & Technologies (QRT)'s ABCL Position: Q3 2026 in Review
Qube Research & Technologies (QRT) opened a new position in AbCellera Biologics (ABCL) in Q3 2026: 41,126 shares worth $600K. The stake represents ﹤0.01% of the portfolio and ranks #2841 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ABCL as recently as Q4 2025.
Qube Research & Technologies (QRT) first reported a position in ABCL in Q4 2021 and has held it in 8 quarters since. The position peaked at $2.62M in Q4 2022. 164 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.
- Qube Research & Technologies (QRT) held 41,126 shares of AbCellera Biologics worth $600K as of Q3 2026.
- AbCellera Biologics was a new Qube Research & Technologies (QRT) position in Q3 2026.
- AbCellera Biologics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2841 holding.
- Qube Research & Technologies (QRT) first reported a position in AbCellera Biologics in Q4 2021 and has held it in 8 quarters since.
- Qube Research & Technologies (QRT)'s AbCellera Biologics position peaked at $2.62M in Q4 2022.
- 164 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.